Foghorn Therapeutics Inc.
FHTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$16 | -$18 | -$19 | -$20 |
| Dep. & Amort. | $1 | $1 | $1 | $1 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $3 | $3 | $2 |
| Change in WC | -$7 | -$8 | -$9 | -$8 |
| Other Non-Cash | $3 | $1 | $1 | -$0 |
| Operating Cash Flow | -$19 | -$21 | -$24 | -$25 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$4 | -$42 | -$51 | -$40 |
| Inv. Sales/Matur. | $40 | $76 | $81 | $62 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $36 | $34 | $29 | $22 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $0 | $0 | $0 |
| Forex Effect | $0 | -$0 | $0 | $0 |
| Net Chg. in Cash | $17 | $13 | $6 | -$2 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $74 | $61 | $57 | $59 |
| End Cash | $91 | $74 | $63 | $57 |
| Free Cash Flow | -$19 | -$21 | -$24 | -$25 |